nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

10.01.2021 | General Gynecology

Opioid use in pregnant women with mental health-related disabilities

verfasst von: Panagiota Kitsantas, Amy R. Adams, Jehanzeb Cheema, Melanie L. Kornides

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to examine associations between opioid use and the degree of mental health-related disability due to emotional/behavioral problems as measured by the World Health Organization Disability Assessment Schedule (WHODAS) instrument in a national sample of pregnant women.

Methods

We used data from the National Survey on Drug Use and Health 2014–2017 which included 2,888 pregnant women 18 years or older. The WHODAS instrument was utilized to measure disability as the degree of functional impairment due to emotional/behavioral problems experienced by the respondent. Multinomial logistic regression models were built to assess the magnitude and direction of the association between severity of mental health-related disability with opioid use and abuse/dependency in the past year.

Results

Approximately 30% of pregnant women suffered from moderate/severe mental health-related disability, and 2% reported opioid abuse/dependency. Compared to those with no opioid use, the odds of opioid use in the past year for individuals with moderate/severe mental health-related disability were 1.73 (95% CI 1.36, 2.21) times higher than those with no/mild disability. Similarly, the odds of opioid abuse/dependency were at least three times higher (OR 3.51; 95% CI 1.80, 6.84) among those with moderate/severe mental health-related disability relative to pregnant women with no/mild disability.

Conclusions

Clinicians should consider screening for both opioid use and mental health conditions and related disabilities using screening tools such as the WHODAS during the initial prenatal visits.

Bateman BT, Hernandez-Diaz S, Rathmell JP et al (2014) Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 120(5):1216–1224. https://doi.org/10.1097/ALN.0000000000000172CrossRefPubMedPubMedCentral

Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts K (2014) Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol 123(5):997–1002. https://doi.org/10.1097/AOG.0000000000000208CrossRefPubMedPubMedCentral

Patrick S, Dudley J, Martin P et al (2015) Prescription opioid epidemic and infant outcomes. Pediatrics 135(5):842–850. https://doi.org/10.1542/peds.2014-3299CrossRefPubMedPubMedCentral

Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM (2018) Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep 67(31):845–849. https://doi.org/10.15585/mmwr.mm6731a1CrossRefPubMedPubMedCentral

Greig E, Ash A, Douiri A (2012) Maternal and neonatal outcomes following methadone substitution during pregnancy. Arch Gynecol Obste 286(4):843–851. https://doi.org/10.1007/s00404-012-2372-9CrossRef

Volkow N (2016) Opioids in pregnancy. BMJ 352:i19. https://doi.org/10.1136/bmj.i19CrossRefPubMed

Faherty L, Matone M, Passarella M, Lorch S (2018) Mental health of mothers of infants with neonatal abstinence syndrome and prenatal opioid exposure. Matern Child Health J 22(6):841–848. https://doi.org/10.1007/s10995-018-2457-6CrossRefPubMed

Arnaudo CL, Andraka-Christou B, Allgood K (2017) Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment. Curr Addict Rep 4(1):1–13. https://doi.org/10.1007/s40429-017-0132-4CrossRefPubMedPubMedCentral

Akobirshoev I, Parish S, Mitra M, Rosenthal E (2017) Birth outcomes among US women with intellectual and developmental disabilities. Disabil Health J 10:406–412. https://doi.org/10.1016/j.dhjo.2017.02.010CrossRefPubMedPubMedCentral

10.

Centers for Disease Control and Prevention (CDC) (2009) Prevalence and most common causes of disability among adults—United States, 2005. MMWR Morb Mortal Wkly Rep 58(16):421–426 (PMID: 19407734)

11.

Vesga-López O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65(7):805–815. https://doi.org/10.1001/archpsyc.65.7.805CrossRefPubMedPubMedCentral

12.

Kerridge BT, Saha TD, Chou SP et al (2015) Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Drug Alcohol Depend 156:47–56. https://doi.org/10.1016/j.drugalcdep.2015.08.026CrossRefPubMedPubMedCentral

13.

Schneider M, Baron E, Davies T, Bass J, Lund C (2015) Making assessment locally relevant: Measuring functioning for maternal depression in Khayelitsha, Cape Town. Soc Psychiatry Psychiatr Epidemiol 50(5):797–806. https://doi.org/10.1007/s00127-014-1003-0CrossRefPubMedPubMedCentral

14.

Silveira C, Souza RT, Costa ML et al (2018) Validation of the WHO Disability Assessment Schedule (WHODAS 2.0) 12-item tool against the 36-item version for measuring functioning and disability associated with pregnancy and history of severe maternal morbidity. Int J Gynaecol Obstet 141(Suppl 1):39–47. https://doi.org/10.1002/ijgo.12465CrossRefPubMedPubMedCentral

15.

Substance Abuse and Mental Health Services Administration (2018) Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18–5068, NSDUH Series H-53). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville. https://www.samhsa.gov/data/

16.

Center for Behavioral Health Statistics and Quality (2018) 2016 National Survey on Drug Use and Health Public Use File Codebook, Substance Abuse and Mental Health Services Administration, Rockville, MD. https://www.datafiles.samhsa.gov/study-dataset/national-survey-drug-use-and-health-2016-nsduh-2016-ds0001-nid17185. Accessed 16 Dec 2020

17.

Center for Behavioral Health Statistics and Quality (2017) Evaluation of imputation methods for the National Survey on drug use and health. Substance Abuse and Mental Health Services Administration, Rockville, MD. https://www.samhsa.gov/data/sites/default/files/NSDUH-PMNImputationMethods2015.pdf. Accessed 16 Dec 2020

18.

Novak SP, Colpe LJ, Barker PR, Gfroerer JC (2010) Development of a brief mental health impairment scale using a nationally representative sample in the U.S.A. Int J Methods Psychiatr Res 19(Suppl 1):49–60. https://doi.org/10.1002/mpr.313CrossRefPubMedPubMedCentral

19.

Center for Behavioral Health Statistics and Quality (2018) 2017 National Survey on drug use and health final analytic file codebook. Substance Abuse and Mental Health Services Administration, Rockville, MD. https://www.datafiles.samhsa.gov/study-dataset/national-survey-drug-use-and-health-2017-nsduh-2017-ds0001-nid17939. Accessed 16 Dec 2020

20.

Aldworth J, Barnett-Walker K, Chromy J, Karg R, et al (2009) Measuring serious mental illness with the NSDUH: Results of 2008 12-month analysis. 2008 National Survey on Drug Use and Health: Methodological resource book (MRB). [Section 16, prepared for the Substance Abuse and Mental Health Services Administration, Contract No. 283-2004-00022, Mental Health Surveillance Study Deliverable 5, RTI/0209009.423.006.008]. RTI International, Research Triangle Park, NC

21.

Center for Behavioral Health Statistics and Quality. (2015). National Survey on Drug Use and Health: Alternative statistical models to predict mental illness. Substance Abuse and Mental Health Services Administration, Rockville, MD. https://www.samhsa.gov/data/sites/default/files/NSDUH-N23-MI-Models-2015.pdf. Accessed 16 Dec 2020

22.

StataCorp (2015) Stata statistical software: release 14. StataCorp LP, College Station

23.

Metz V, Brown Q, Martins S, Palamar J (2018) Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug Alcohol Depend 183:261–266. https://doi.org/10.1016/j.drugalcdep.2017.11.010CrossRefPubMed

24.

Kozhimannil K, Graves A, Levy R, Patrick S (2017) Non-medical use of prescription opioids among pregnant US women. Womens Health Issues 27(3):308–315. https://doi.org/10.1016/j.whi.2017.03.001CrossRefPubMedPubMedCentral

25.

Scherrer JF, Salas J, Copeland LA et al (2016) Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Fam Med 14(1):54–62. https://doi.org/10.1370/afm.1885CrossRefPubMedPubMedCentral

26.

Upadhyay J, Maleki N, Potter J et al (2010) (2010) Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 133(7):2098–2114. https://doi.org/10.1093/brain/awq138CrossRefPubMedPubMedCentral

27.

Jones S, Bonci A (2005) Synaptic plasticity and drug addiction. Curr Opin Pharmacol 5(1):20–25. https://doi.org/10.1016/j.coph.2004.08.011CrossRefPubMed

28.

American College of Obstetricians and Gynecologists (2017) Committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol 130(2):e81–e94. https://doi.org/10.1097/AOG.0000000000002235CrossRef

Titel: Opioid use in pregnant women with mental health-related disabilities
verfasst von: Panagiota Kitsantas
Amy R. Adams
Jehanzeb Cheema
Melanie L. Kornides
Publikationsdatum: 10.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2021
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-020-05953-0

Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants

Open Access
General Gynecology

Predicting postpartum post-traumatic stress and depressive symptoms in low-risk women from distal and proximal factors: a biopsychosocial prospective study using structural equation modeling

Maternal-Fetal Medicine

The effect of folate on ischemia/reperfusion injury in a rat adnexal torsion model

General Gynecology

Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal study

General Gynecology

Transferability of the early-stage ovarian malignancy (EOM) score: an external validation study that includes advanced-stage and metastatic ovarian cancer

General Gynecology

ITRAQ-based proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells of adenomyosis

General Gynecology

Neu im Fachgebiet Gynäkologie und Geburtshilfe

KI-gestütztes Mammografiescreening überzeugt im Praxistest

16.01.2025
Künstliche Intelligenz im Gesundheitswesen
Nachrichten

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Einer von sieben Frauen macht die Menopause sehr zu schaffen

15.01.2025
Menopause
Nachrichten

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

12.01.2025
Elektronische Patientenakte
Nachrichten

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Keine eingeschränkten Kassenleistungen bei Schwangerschaft nach IVF

Medikamente in Schwangerschaft und Stillzeit
Nachrichten

Nach privat bezahlter In-vitro-Fertilisation muss die gesetzliche Krankenkasse ein Arzneimittel zum Erhalt der Schwangerschaft bezahlen, so ein Urteil des Sozialgerichts in München.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Opioid use in pregnant women with mental health-related disabilities